Nuclear Medicine and Biology
Volume 35, Issue 5 , Pages 537-542 , July 2008

Rapid and efficient radiosynthesis of [123I]I-PK11195, a single photon emission computed tomography tracer for peripheral benzodiazepine receptors

  • Sally L. Pimlott

      Affiliations

    • Department of Clinical Physics, West of Scotland Radionuclide Dispensary, Western Infirmary, G11 6NT Glasgow, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 141 211 2887; fax: +44 141 211 2552.
    • ,
  • Louise Stevenson

      Affiliations

    • Department of Chemistry, WestCHEM, University of Glasgow, G12 8QQ Glasgow, UK
    • ,
  • David J. Wyper

      Affiliations

    • Institute of Neurological Sciences, Southern General Hospital, G51 4TF Glasgow, UK
    • ,
  • Andrew Sutherland

      Affiliations

    • Department of Chemistry, WestCHEM, University of Glasgow, G12 8QQ Glasgow, UK

Received 15 January 2008 ,Accepted 11 February 2008.

References 

  1. Richards JG, Mohler H. Benzodiazepine receptors. Neuropharmacology. 1984;23:233–242
  2. Galiegue S, Tinel N, Casellas P. The peripheral benzodiazepine receptor: a promising therapeutic drug target. Curr Med Chem. 2003;10:1563–1572
  3. Banati RB. Visualising microglial activation in vivo. Glia. 2002;40:206–217
  4. Gonzalez-Scarano F, Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci. 1999;22:219–240
  5. Camsonne R, Crouzel C, Comar D, Maziere M, Prenant C, Sastre J, et al. Synthesis of N-(C-11) methyl, N-(methyl-1 propyl), (chloro-2 phenyl)-1 isoquinoleine carboxamide-3 (Pk-11195) — a new ligand for peripheral benzodiazepine receptors. J Labelled Compd Radiopharm. 1984;21:985–991
  6. Hashimoto K, Inoue O, Suzuki K, Yamasaki T, Kojima M. Synthesis and evaluation of 11C-PK 11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography. Ann Nucl Med. 1989;3:63–71
  7. Gildersleeve DL, VanDort ME, Johnson JW, Sherman PS, Wieland DM. Synthesis and evaluation of [I-123]-iodo-PK11195 for mapping peripheral-type benzodiazepine receptors (omega(3)) in heart. Nucl Med Biol. 1996;23:23–28
  8. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, et al. In-vivo measurement of activated microglia in dementia. Lancet. 2001;358:461–467
  9. Versijpt JJ, Dumont F, Van Laere KJ, Decoo D, Santens P, Audenaert K, et al. Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study. Eur Neurol. 2003;50:39–47
  10. Banati RB, Goerres GW, Myers R, Gunn RN, Turkheimer FE, Kreutzberg GW, et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology. 1999;53:2199–2203
  11. Cagnin A, Myers R, Gunn RN, Lawrence AD, Stevens T, Kreutzberg GW, et al. In vivo visualization of activated glia by [11C](R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain. 2001;124:2014–2027
  12. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain. 2000;123(Pt 11):2321–2337
  13. Gerhard A, Banati RB, Goerres GB, Cagnin A, Myers R, Gunn RN, et al. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology. 2003;61:686–689
  14. Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, et al. In vivo imaging of microglial activation with [(11)C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol Dis. 2006;21:404–412
  15. Gerhard A, Neumaier B, Elitok E, Glatting G, Ries V, Tomczak R, et al. In vivo imaging of activated microglia using [11C]PK11195 and positron emission tomography in patients after ischemic stroke. Neuroreport. 2000;11:2957–2960
  16. Gerhard A, Schwarz J, Myers R, Wise R, Banati RB. Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage. 2005;24:591–595
  17. Pappata S, Levasseur M, Gunn RN, Myers R, Crouzel C, Syrota A, et al. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology. 2000;55:1052–1054
  18. Gildersleeve DL, Lin TY, Wieland DM, Ciliax BJ, Olson JM, Young AB. Synthesis of a high specific activity 125I-labeled analog of PK 11195, potential agent for SPECT imaging of the peripheral benzodiazepine binding site. Int J Rad Appl Instrum B. 1989;16:423–429
  19. Stevenson L, Pimlott SL, Sutherland A. A novel approach for the synthesis of the peripheral benzodiazepine receptor ligand, PK11195. Tetrahedron Lett. 2007;48:7137–7139
  20. Klapars A, Buchwald SL. Copper-catalysed halogen exchange in aryl halides: an aromatic Finkelstein reaction. J Am Chem Soc. 2002;124:14844–14845

PII: S0969-8051(08)00070-X

doi: 10.1016/j.nucmedbio.2008.02.013

Nuclear Medicine and Biology
Volume 35, Issue 5 , Pages 537-542 , July 2008

Article Tools

* Image Usage & Resolution